Literature DB >> 6534748

Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction.

D Alexopoulos, A E Raine, S M Cobbe.   

Abstract

A case of delayed serum sickness with transient renal impairment is described in a patient who received early high dose intravenous streptokinase following acute myocardial infarction. Review of the literature suggests that serum sickness after streptokinase may occur independently of the dose or route of administration, and could potentially complicate intracoronary streptokinase therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6534748     DOI: 10.1093/oxfordjournals.eurheartj.a061602

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.

Authors:  K A Davies; P Mathieson; C G Winearls; A J Rees; M J Walport
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

2.  Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

Authors:  C Bucknall; C Darley; J Flax; R Vincent; D Chamberlain
Journal:  Br Heart J       Date:  1988-01

3.  Rash after treatment with anistreplase.

Authors:  N Burrows; R R Jones
Journal:  Br Heart J       Date:  1990-10

4.  A new skin lesion associated with intravenous streptokinase.

Authors:  J E Smithson; C T Kennedy; S Hughes
Journal:  BMJ       Date:  1993-04-10

5.  Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.

Authors:  Y Birnbaum; B Strasberg; E Rechavia; Y Neuman; B Stahl
Journal:  West J Med       Date:  1993-04

6.  Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

Authors:  M Lynch; W A Littler; B L Pentecost; R A Stockley
Journal:  Br Heart J       Date:  1991-08

7.  Why do patients develop reactions to streptokinase?

Authors:  M Lynch; B L Pentecost; W A Littler; R A Stockley
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

8.  Henoch-Schoenlein purpura due to streptokinase.

Authors:  A P Zilliox; D T Domoto; P S Hutcheson; C C Tsai; R G Slavin
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.